Chris Smith
InvestorPartner at Brandon Capital Partners
Find your path to Chris
1 person in our graph can introduce you to Chris.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kip Dudgeon to introduce you to Chris
You →Kip · together at Brandon Capital Partners →Chris
Sign up to find every way you can get introduced to Chris
- Your email: the people you already email who know Chris
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Chris
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Chris joined Brandon Capital in 2012 and previously worked as a Business Development Manager at CSL and as a postdoctoral scientist at the University of Cambridge. He serves as a director of several portfolio companies including Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, and holds a PhD in Immunology and an MBA from Cambridge.
Frequently asked questions
- Who is Chris Smith?
- Chris joined Brandon Capital in 2012 and previously worked as a Business Development Manager at CSL and as a postdoctoral scientist at the University of Cambridge. He serves as a director of several portfolio companies including Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, and holds a PhD in Immunology and an MBA from Cambridge.
- Where does Chris Smith work?
- Chris Smith is Partner at Brandon Capital Partners.

